Conditions: Hypercholesterolemia
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 173
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the safety and tolerability of ezetimibe/simvastatin in patients newly diagnosed with dyslipidemia.

Detailed description:

Arms:
arm 1: Patients with intermediate or high risk dyslipidemia will be enrolled to receive treatment with Vytorin 10/20 (ezetimibe 10 mg /simvastatin20 mg) tablet once daily consecutively for 6 weeks

Interventions: intervention 1: ezetimibe (+) simvastatin
Intervention descriptions: intervention 1: Vytorin 10/20 (ezetimibe 10 mg /simvastatin20 mg) tablet once daily consecutively for 6 weeks.

Protocol document: